One of the world’s leading healthcare companies has completed its acquisition of the biopharmaceutical company commercialising The University of Queensland's Molecular Clamp technology.
Sanofi entered into an agreement earlier this year to acquire Vicebio, a company formed in 2018 to develop UQ’s Molecular Clamp technology to make vaccines against life-threatening respiratory viral infections.
